It is a pharma private limited company based in Vadodara, Gujarat, India, established in 2020.
2020 | Vadodara, Gujarat, India | ActiveRemeris Pharma Private Limited, a active private limited company, was established on 24 January 2020 in Vadodara, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24119GJ2020PTC112272. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Bharat Harivallavdas Shah (Director), Dhaval Rajnikant Zaveri (Director), Piyush Chaturbhai Patel (Director). Past directors included Bharat Harivallavdas Shah, Dhaval Rajnikant Zaveri, Rashmi Piyshbhai Patel. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at T.F. 305 Safron Complex, Opp. Camps Corner, Fatehgunj, Vadodara, Gujarat, 390002.
U24119GJ2020PTC112272
112272
24 January 2020
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Remeris Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharat Harivallavdas Shah | Director | 28 Jan 2022 | Current |
| Dhaval Rajnikant Zaveri | Director | 28 Jan 2022 | Current |
| Piyush Chaturbhai Patel | Director | 24 Jan 2020 | Current |
| Dhavalkumar Chhotalal Barot | Director | 25 Oct 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 28 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Remeris Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2020, Remeris Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Remeris Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Remeris Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remeris Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Remeris Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Remeris Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity Bharat Harivallavdas Shah was appointed as a Director was appointed as a Director on 28 Jan 2022 & has been associated with this company since 3 years 10 months . was completed.
Progress on Dhaval Rajnikant Zaveri was appointed as a Director was appointed as a Director on 28 Jan 2022 & has been associated with this company since 3 years 10 months . was documented.
Progress on Dhavalkumar Chhotalal Barot was appointed as a Director was appointed as a Director on 25 Oct 2021 & has been associated with this company since 4 years 1 month . was documented.
The activity Piyush Chaturbhai Patel was appointed as a Director was appointed as a Director on 24 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
The CIN of Remeris Pharma Private Limited is U24119GJ2020PTC112272.
Remeris Pharma Private Limited is headquartered at T.F. 305 Safron Complex, Opp. Camps Corner, Fatehgunj, Vadodara, Gujarat, 390002.
Remeris Pharma Private Limited was incorporated on 24 January 2020.
The current directors of Remeris Pharma Private Limited are
The primary industry of Remeris Pharma Private Limited is Manufacturing.
Remeris Pharma Private Limited is unlisted.
The authorized capital of Remeris Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX